• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

痛风患者失访的危险因素:一项韩国前瞻性队列研究。

Risk factors for loss to follow-up in patients with gout: A Korean prospective cohort study.

作者信息

Do Hyunsue, Son Chang-Nam, Choi Hyo Jin, Kim Ji Hyoun, Kim Min Jung, Shin Kichul, Kim Sang-Hyon, Choi Byoongyong, Ha You-Jung, Ahn Joong Kyong, Kim Hyun-Ok, Lee Sung Won, Lee Chang Hoon, Song Ran, Son Kyeong Min, Lee Seung-Geun, Moon Ki Won

机构信息

Division of Rheumatology, Department of Internal Medicine, Kangwon National University School of Medicine, Chuncheon, Gangwon-do, Republic of Korea.

Division of Rheumatology, Department of Internal Medicine, Eulji University School of Medicine, Uijeongbu, Gyeonggi-do, Republic of Korea.

出版信息

PLoS One. 2025 Feb 7;20(2):e0318564. doi: 10.1371/journal.pone.0318564. eCollection 2025.

DOI:10.1371/journal.pone.0318564
PMID:39919085
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11805391/
Abstract

OBJECTIVES

Gout, a common form of inflammatory arthritis, is often managed with urate-lowering therapy, but many patients only adhere to treatment during gout attacks, resulting in poor follow-up and suboptimal management. This study aimed to identify characteristics associated with loss to follow-up (LTFU) and develop strategies for better patient management.

METHODS

Data were analyzed from the Urate Lowering TheRApy in gout (ULTRA) registry, a prospective cohort of Korean gout patients recruited since September 2021. Patients aged 18 or older who met the 2015 ACR/EULAR classification criteria were included. Demographic data, clinical characteristics, lifestyle habits, comorbidities, and quality of life assessments using the Korean Gout Impact Scale (K-GIS) and EuroQol 5-Dimension (EQ-5D) were collected at baseline, six months, and annually. LTFU was defined as missing a clinic visit for more than a year. Logistic regression was used to determine factors associated with LTFU.

RESULTS

Among 269 patients, 125 (46.5%) were classified as LTFU. Patients not lost to follow-up experienced more frequent gout attacks (P = 0.020) and expressed greater concerns about future flares (P = 0.034). In contrast, LTFU patients had higher levels of anxiety (P = 0.049), depressive symptoms (P = 0.009), impaired mobility (P = 0.002), and a higher EQ-5D score (P = 0.002). Logistic regression identified frequent gout attacks, concerns about attacks, anxiety, impaired mobility, and EQ-5D scores as significant predictors of LTFU.

CONCLUSION

Fewer gout attacks, heightened anxiety and depression, and lower quality of life were key factors associated with LTFU. Providing emotional support and comprehensive education may enhance follow-up and improve gout management.

摘要

目的

痛风是炎症性关节炎的常见形式,通常采用降尿酸治疗,但许多患者仅在痛风发作时坚持治疗,导致随访不佳和管理不理想。本研究旨在确定与失访(LTFU)相关的特征,并制定改善患者管理的策略。

方法

对痛风降尿酸治疗(ULTRA)登记处的数据进行分析,该登记处是自2021年9月起招募的韩国痛风患者的前瞻性队列。纳入符合2015年美国风湿病学会/欧洲抗风湿病联盟分类标准的18岁及以上患者。在基线、6个月和每年收集人口统计学数据、临床特征、生活习惯、合并症以及使用韩国痛风影响量表(K-GIS)和欧洲五维健康量表(EQ-5D)进行的生活质量评估。LTFU定义为错过门诊就诊超过一年。采用逻辑回归确定与LTFU相关的因素。

结果

在269例患者中,125例(46.5%)被归类为LTFU。未失访的患者痛风发作更频繁(P = 0.020),对未来发作表示出更大的担忧(P = 0.034)。相比之下,LTFU患者焦虑水平更高(P = 0.049)、有抑郁症状(P = 0.009)、行动能力受损(P = 0.002)且EQ-5D评分更高(P = 0.002)。逻辑回归确定痛风发作频繁、对发作的担忧、焦虑、行动能力受损和EQ-5D评分是LTFU的重要预测因素。

结论

痛风发作较少、焦虑和抑郁加剧以及生活质量较低是与LTFU相关的关键因素。提供情感支持和全面教育可能会加强随访并改善痛风管理。

相似文献

1
Risk factors for loss to follow-up in patients with gout: A Korean prospective cohort study.痛风患者失访的危险因素:一项韩国前瞻性队列研究。
PLoS One. 2025 Feb 7;20(2):e0318564. doi: 10.1371/journal.pone.0318564. eCollection 2025.
2
Reliability and Validity of the Korean Version of the Gout Impact Scale.痛风影响量表韩国版的信度和效度。
J Korean Med Sci. 2023 Sep 4;38(35):e266. doi: 10.3346/jkms.2023.38.e266.
3
High vegetable consumption and regular exercise are associated with better quality of life in patients with gout.高蔬菜摄入量和定期运动与痛风患者的生活质量改善相关。
Korean J Intern Med. 2024 Sep;39(5):845-854. doi: 10.3904/kjim.2023.476. Epub 2024 Jun 24.
4
Effects of Genetic Risk and Lifestyle Habits on Gout: A Korean Cohort Study.遗传风险和生活方式习惯对痛风的影响:一项韩国队列研究。
J Korean Med Sci. 2025 Jan 13;40(2):e1. doi: 10.3346/jkms.2025.40.e1.
5
Gout during the SARS-CoV-2 pandemic: increased flares, urate levels and functional improvement.SARS-CoV-2 大流行期间的痛风:发作增加、尿酸水平升高和功能改善。
Clin Rheumatol. 2022 Mar;41(3):811-818. doi: 10.1007/s10067-021-05994-z. Epub 2021 Nov 25.
6
Seasonal Variations and Associated Factors of Gout Attacks: a Prospective Multicenter Study in Korea.韩国一项前瞻性多中心研究:痛风发作的季节性变化及相关因素。
J Korean Med Sci. 2020 May 25;35(20):e133. doi: 10.3346/jkms.2020.35.e133.
7
Are Target Urate and Remission Possible in Severe Gout? A Five-year Cohort Study.严重痛风患者的降尿酸目标和缓解可能实现吗?一项为期 5 年的队列研究。
J Rheumatol. 2020 Jan;47(1):132-139. doi: 10.3899/jrheum.181214. Epub 2019 May 1.
8
Gout characteristics associate with depression, but not anxiety, in primary care: Baseline findings from a prospective cohort study.在初级保健中,痛风特征与抑郁症相关,但与焦虑症无关:一项前瞻性队列研究的基线结果
Joint Bone Spine. 2016 Oct;83(5):553-8. doi: 10.1016/j.jbspin.2015.10.008. Epub 2016 Apr 7.
9
Factors Associated with Nonreturn after Loss to Follow-Up from Glaucoma Care: An IRIS® Registry Retrospective Analysis.与青光眼护理随访失访后不回诊相关的因素:IRIS® 注册回顾性分析。
Ophthalmol Glaucoma. 2024 Nov-Dec;7(6):572-579. doi: 10.1016/j.ogla.2024.07.007. Epub 2024 Jul 20.
10
Predictors of loss to follow up among patients with type 2 diabetes mellitus attending a private not for profit urban diabetes clinic in Uganda - a descriptive retrospective study.乌干达一家私立非营利性城市糖尿病诊所 2 型糖尿病患者随访丢失的预测因素——一项描述性回顾性研究。
BMC Health Serv Res. 2019 Aug 23;19(1):598. doi: 10.1186/s12913-019-4415-4.

本文引用的文献

1
Prevalence and treatment rate of gout by depressive symptom severity: A cross-sectional analysis of NHANES 2007-2018.基于 2007-2018 年 NHANES 横断面研究的抑郁症状严重程度与痛风患病率和治疗率的关系
Int J Rheum Dis. 2024 Jan;27(1):e14959. doi: 10.1111/1756-185X.14959. Epub 2023 Nov 20.
2
Reliability and Validity of the Korean Version of the Gout Impact Scale.痛风影响量表韩国版的信度和效度。
J Korean Med Sci. 2023 Sep 4;38(35):e266. doi: 10.3346/jkms.2023.38.e266.
3
Epidemiology and treatment-related concerns of gout and hyperuricemia in Korean.韩国痛风和高尿酸血症的流行病学及与治疗相关的问题
J Rheum Dis. 2023 Apr 1;30(2):88-98. doi: 10.4078/jrd.2022.0001. Epub 2023 Mar 17.
4
The aftermath of Urate-Lowering TheRApy in gout (ULTRA) registry: The first prospective observational multicenter cohort of Korean patients with gout.痛风降尿酸治疗(ULTRA)登记研究的后续情况:韩国痛风患者的首个前瞻性观察性多中心队列研究。
Int J Rheum Dis. 2023 Jun;26(6):1015-1018. doi: 10.1111/1756-185X.14666.
5
A glance into the future of gout.痛风的未来展望
Ther Adv Musculoskelet Dis. 2022 Jul 28;14:1759720X221114098. doi: 10.1177/1759720X221114098. eCollection 2022.
6
WeChat-based education and rehabilitation program in unprotected left main coronary artery disease patients after coronary artery bypass grafting: an effective approach in reducing anxiety, depression, loss to follow-up, and improving quality of life.基于微信的教育和康复计划在冠状动脉旁路移植术后无保护左主干冠状动脉疾病患者中的应用:一种有效降低焦虑、抑郁、失访率和提高生活质量的方法。
Braz J Med Biol Res. 2021 Feb 12;54(4):e10370. doi: 10.1590/1414-431X202010370. eCollection 2021.
7
High Rate of Adherence to Urate-Lowering Treatment in Patients with Gout: Who's to Blame?痛风患者尿酸降低治疗的高依从率:该归咎于谁?
Rheumatol Ther. 2020 Dec;7(4):1011-1019. doi: 10.1007/s40744-020-00249-w. Epub 2020 Oct 28.
8
Use of the Gout Impact Scale to Evaluate Quality of Life in Chinese Subjects with Gout: A Cross-Sectional Study.使用痛风影响量表评估中国痛风患者的生活质量:一项横断面研究。
Med Sci Monit. 2020 Sep 29;26:e925593. doi: 10.12659/MSM.925593.
9
Epidemiology of Depression and Anxiety in Gout: A Systematic Review and Metaanalysis.痛风患者抑郁和焦虑的流行病学:系统评价和荟萃分析。
J Rheumatol. 2021 Jan 1;48(1):129-137. doi: 10.3899/jrheum.190974. Epub 2020 Mar 1.
10
Better outcomes for patients with gout.改善痛风患者的治疗效果。
Inflammopharmacology. 2020 Oct;28(5):1395-1400. doi: 10.1007/s10787-020-00694-7. Epub 2020 Feb 25.